bpc-157 fda warning news 2025 BPC-157: Evidence-Based Information for Regenerative Medicine fda bpc-157 safety risks compounding

Pale skin Heart palpitations Shortness of breath A smooth tongue Vision loss Constipation Loss of appetite Diarrhea Gas Vision loss Mental problems like depression, memory loss, or behavioral changes Nerve problems like numbness or tingling, muscle weakness, and problems walking

Most people notice initial effects within the first few weeks, with more significant results appearing over several months

DrugBank Online | Database for Drug and Drug Target Info

Mild headaches: Some users report headaches during the first week of use

Precautions and Potential Interactions Exercise caution when using BPC-157 and TB-500 capsules in subjects with a history of allergies or sensitivities